| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |